Results
Get to know Qing Cai
Meet Qing, our Business Developer at VUB TechTransfer. She specializes in helping researchers turn their applied research into products or services, specifically in the Brussels area. To get to know our team better, Qing is sharing her story today. What is your role at VUB TechTransfer?
Read more
TechTransfer Talks
Introducing TechTransfer Talks - every three months, we provide expert insights on a range of topics, including legal issues, IP rights, and entrepreneurship. Stay updated by visiting this page for upcoming events.
Read more
TechTransfer Talk: Female Entrepreneurship
Practical info
7 March 2023 12:00
-
7 March 2023 14:00
A debate featuring Yasmien Naciri (author and columnist), Sofie Baeten (Qbic Fund) and Elien Van Hecke (co-founder of Lavima, a VUB spin-off) Moderated by Marc Goldchstein, the panel will delve into the difficulties faced by female entrepreneurs and explore the possibil...
Read more
From demolition towards preservation: A paradigm shift for Brussels building sector
Why are buildings being demolished and how can we influence decision making processes of building teams? How do narratives on the city and architectural taste influence whether a building will be demolished?
Read more
VUB invests in applied research with IOF funding
The Industrial Research Fund (IOF) is an earmarked University Association Fund that is annually fed with a block grant from the Flemish Government.
Read more
Next step in corrosion prevention for cars
Nowadays new cars mainly consist of the very light metal aluminum and magnesium, which are not directly connected to corrosion. But that isn't quite right.
Read more
VUB scientists can re-implant previously collected testicular tissue in men after cancer treatment
The VUB research group Biology of the Testis (BITE) of Prof. Ellen Goossens (together with UZ Brussel) will be the first worldwide to re-implant previously collected testicular tissue in men, who do not produce sperm cells as a result of cancer treatment at a young age.
Read more
Start-up Esobiotec pursues affordable cancer immunotherapy
The VUB is an Urban Engaged University that is firmly committed to the fight against cancer through scientific research.
Read more
eTheRNA announces research agreement with Merck to access mRNA technologies
eTheRNA immunotherapies announces the start of a strategic partnership with Merck with the signing of a Research Agreement. The partnership will investigate the application of eTheRNA’s proprietary mRNA design expertise and LNP-delivery platforms to disease areas selected by Merck.
Read more
Brussels grants spin-off Axiles Bionics
VUB spin-off Axiles Bionics won the Innovative Starters Award 2021. With the Innovative Starters Award (ISA) programme, Innoviris annually supports ambitious start-ups & scale-ups that are striving for an effective strategic breakthrough. Axiles Bionics aims to deve...
Read more